Tablo Announces $76.5M Investment.

*Bringing its total to $185.5M, Outset Medical announces a new investment from T. Row Price Associates. The Tablo machine is rethinking HD technology from the ground up. A minifridge-sized unit can purify tap water, send and receive data, and even clear air bubbles from the dialyzer and bloodlines.

Read the full article » | Posted 06-12-2017

Related Articles

• Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
• AWAK PD To Go Posted 10-05-2026
• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026